801![NHS Improving Quality Transforming End of Life Care in Acute Hospitals Programme (Transform Programme) Factsheet 1: Sources of data and resources NHS Improving Quality Transforming End of Life Care in Acute Hospitals Programme (Transform Programme) Factsheet 1: Sources of data and resources](https://www.pdfsearch.io/img/669ef800b7cbf009084bdd231ea1ac11.jpg) | Add to Reading ListSource URL: www.nhsiq.nhs.ukLanguage: English - Date: 2014-06-11 06:57:59
|
---|
802![Trials BioMed Central Open Access Trials BioMed Central Open Access](https://www.pdfsearch.io/img/e344744c73c99e5dea4d6277c25ad4d8.jpg) | Add to Reading ListSource URL: www.trialsjournal.comLanguage: English |
---|
803![Using Additional Questions with the CIRP Freshman Survey Adding Additional Questions to the Survey Campuses have the option of adding up to 20 additional multiple choice questions of specific local interest at the end of Using Additional Questions with the CIRP Freshman Survey Adding Additional Questions to the Survey Campuses have the option of adding up to 20 additional multiple choice questions of specific local interest at the end of](https://www.pdfsearch.io/img/ebe9537c71e8efcc2509691f614dea5f.jpg) | Add to Reading ListSource URL: www.heri.ucla.eduLanguage: English - Date: 2015-01-20 19:57:44
|
---|
804![Intersect ENT Announces Positive Data from Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Results Presented at the Annual American Rhinologic Society Meeting 2014; Recognized with Cottle Award fo Intersect ENT Announces Positive Data from Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Results Presented at the Annual American Rhinologic Society Meeting 2014; Recognized with Cottle Award fo](https://www.pdfsearch.io/img/e50c2e9e029ffe9c3b5a8b8b04deecd4.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2014-09-22 08:56:58
|
---|
805![April 29, 2013 Astex Pharmaceuticals Reports 2013 First Quarter Financial Results Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First q April 29, 2013 Astex Pharmaceuticals Reports 2013 First Quarter Financial Results Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First q](https://www.pdfsearch.io/img/dc1bfaaceb09de9bc5af98fbc38f234c.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
806![Dear Reader : Pharmaceutical and vaccine research and development increasingly promise new therapies and preventions for infectious diseases, including HIV/AIDS, as well noncommunicable diseases, such as cancers, arthrit Dear Reader : Pharmaceutical and vaccine research and development increasingly promise new therapies and preventions for infectious diseases, including HIV/AIDS, as well noncommunicable diseases, such as cancers, arthrit](https://www.pdfsearch.io/img/dc2226e905ecde1baf1a6afd31d796e3.jpg) | Add to Reading ListSource URL: www.who.intLanguage: English - Date: 2005-06-02 12:50:04
|
---|
807![News Release Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results SGI-110 clinical data presented at EHA for Phase 1 MDS patients Second quarter royalty revenue increased 15% to $16.6 million Royalty reven News Release Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results SGI-110 clinical data presented at EHA for Phase 1 MDS patients Second quarter royalty revenue increased 15% to $16.6 million Royalty reven](https://www.pdfsearch.io/img/7ec952fad1b54641ddf12d718669fd67.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
808![To The Point May June[removed]Influenza vaccine Current HNE influenza data shows that the three influenza strains notified in HNE are the three strains covered in the 2011 influenza vaccine - please continue to offer i To The Point May June[removed]Influenza vaccine Current HNE influenza data shows that the three influenza strains notified in HNE are the three strains covered in the 2011 influenza vaccine - please continue to offer i](https://www.pdfsearch.io/img/ae99230965e674218fe3001c688dc0ca.jpg) | Add to Reading ListSource URL: www.hnehealth.nsw.gov.auLanguage: English |
---|
809![HPB Cancer Measurability of Quality Performance Indicators Version 2.3 To be read in conjunction with: HPB Cancer Clinical Quality Performance Indicators HPB Cancer Data Definitions (latest published version) HPB Cancer Measurability of Quality Performance Indicators Version 2.3 To be read in conjunction with: HPB Cancer Clinical Quality Performance Indicators HPB Cancer Data Definitions (latest published version)](https://www.pdfsearch.io/img/65a7269641d3d19eac80973a762bde0c.jpg) | Add to Reading ListSource URL: www.isdscotland.orgLanguage: English - Date: 2014-12-01 11:52:23
|
---|
810![Eisai and Janssen Announce the Presentation of DACOGENĀ® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann Eisai and Janssen Announce the Presentation of DACOGENĀ® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann](https://www.pdfsearch.io/img/3325c30b9cbfe3929dc5122b51a04176.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|